Radiation Treatment of the Prostate That is Specially Adjusted for Each Person

A number of recent studies have successfully reduced the number of radiotherapy treatments used for prostate cancer from 39 daily treatments to as little as 5 treatments. This study is designed to determine how tumors inside the prostate respond during these 5 treatments on magnetic resonance imaging (MRI) and use that information to design 2 fraction radiotherapy treatments for prostate cancer. For these two fraction treatments, the first fraction of radiation will use extra radiation to any nodules in the prostate, and the second fraction of radiation will give extra radiation to the nodule

Trial Details

NCT ID
NCT07578519
Phase
PHASE2
Sponsor
AHS Cancer Control Alberta
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • radiotherapy
Locations (sample)
  • Lethbridge, Alberta, Canada|49.69999,-112.81856

Key Eligibility Criteria

  • Histologically confirmed adenocarcinoma of the prostate
  • NCCN risk grouping of intermediate or high risk prostate cancer
  • Patients must be 18 years of age, or older on the day of signing informed consent and be willing and able to provide written informed consent/assent
  • Identifiable lesion within the epithelium of the prostate as determined by the treating radiation oncologist

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →